Written by the Nuvirox Research Team
Key Points
- A 2025 network meta-analysis of 39 randomized trials found Boswellia extracts significantly improved pain, stiffness, and function in knee osteoarthritis.
- A 120-day placebo-controlled trial found a standardized Boswellia extract reduced pain and stiffness while also improving radiographic knee joint measurements.
- Effect sizes and quality vary a lot by which specific standardized extract was tested, so 'Boswellia' as a category is more consistently supported than any one brand-name extract.
Short answer: yes, Boswellia serrata has some of the stronger trial support among plant-derived joint supplements, though results vary by extract. Multiple randomized trials and a recent large meta-analysis point the same direction — toward real, if moderate, benefit for knee osteoarthritis pain and stiffness.
What is Boswellia serrata and how might it work?
Boswellia serrata is a tree native to India and North Africa; its resin (sometimes called Indian frankincense) contains boswellic acids, compounds studied for their ability to inhibit 5-lipoxygenase, an enzyme involved in producing inflammatory leukotrienes. That's a different inflammatory pathway than the COX pathway NSAIDs target, which is part of why some researchers have proposed Boswellia and NSAIDs might work through complementary mechanisms rather than duplicating each other.
Does it matter which Boswellia extract you use?
Yes, more than with most supplements in this category. Boswellic acid content and the ratio of specific acids (like AKBA, a particularly potent one) vary substantially between raw gum resin and standardized extracts, and different manufacturers use different extraction and standardization processes. Several of the positive trials used branded, standardized extracts (like Aflapin® or Boswellin®) rather than generic Boswellia powder, so results don't necessarily generalize to every product labeled 'Boswellia serrata' on a shelf.
What human studies actually show
Majeed et al., 2019 — 120-day RCT, 48 adults, knee OA. A standardized Boswellia serrata extract significantly improved physical function by reducing pain and stiffness compared with placebo. Radiographic assessments also showed improved knee joint space and reduced osteophytes (bone spurs), and the extract significantly lowered high-sensitivity CRP, an inflammatory marker.1 No serious adverse events were reported.
Zhang et al., 2025 — network meta-analysis, 39 RCTs, knee OA. This recent, large synthesis of the Boswellia trial literature found it significantly improved pain, stiffness, and function compared with placebo across the pooled data.2 Network meta-analyses that combine dozens of trials with different extracts and doses inevitably average over real differences between products, which is the honest caveat here — the category shows a consistent signal, but 'Boswellia' isn't one single, standardized intervention.
Study Snapshot: Majeed et al., 2019 RCT
| Design | 120-day, randomized, double-blind, placebo-controlled |
| Participants | 48 adults with knee osteoarthritis |
| Extract | Standardized Boswellia serrata extract (branded) |
| Primary result | Significant reduction in pain & stiffness vs. placebo |
| Secondary result | Lower hs-CRP and improved radiographic joint space |
What Boswellia won't do
Boswellia's evidence is for symptom improvement, primarily in knee osteoarthritis; it isn't shown to reverse existing joint damage, even though one trial found modest improvement in a radiographic measure. Which specific extract and dose were used matters more here than in some other categories, so results with one product don't guarantee the same with another. Mild GI upset is the most commonly reported side effect in trials. As always, new or worsening joint pain with swelling, warmth, or fever should be evaluated by a doctor rather than managed with a supplement alone.
What doses were studied
The 120-day trial above used a standardized extract dosed to deliver a specific boswellic acid content daily (not disclosed here as an exact milligram figure since formulations vary by brand); the broader meta-analysis literature spans doses generally in the 100–250 mg/day range of concentrated boswellic acid extract, taken for 4–16 weeks depending on the trial.
Frequently Asked Questions
Is Boswellia the same as frankincense you'd burn as incense?
They come from the same tree resin, but supplement extracts are standardized and concentrated for boswellic acid content, unlike incense-grade resin.
How fast does Boswellia work?
Some trials have reported early changes within 5–7 days, though most primary outcomes were assessed at 4–16 weeks.
Can Boswellia be combined with turmeric/curcumin?
Several trials have tested Boswellia-curcumin combinations with promising results, though combination products introduce more variables to isolate which ingredient is doing what.
Are there interactions to watch for?
Boswellia hasn't shown the same anticoagulant-interaction signal as glucosamine or bromelain in the literature, but check with a doctor if you're on other medications, especially long-term ones.
How does Boswellia compare to NSAIDs directly?
Head-to-head comparative trials are more limited than for turmeric, but Boswellia's proposed mechanism (5-lipoxygenase inhibition) is different from the COX pathway NSAIDs target, which is part of the rationale for combining the two rather than viewing them as interchangeable.
Is there a 'best' boswellic acid to look for on a label?
AKBA (3-acetyl-11-keto-beta-boswellic acid) is the specific boswellic acid most studied for potency in laboratory research, and several of the standardized extracts used in positive trials are concentrated for it specifically.
How quickly did people notice improvement in the trials?
Most primary outcomes in the trial literature were assessed at 4 to 16 weeks, though at least one recent multi-center trial reported some improvement within the first five days of use, suggesting the onset speed may vary by extract and dose.
Does Boswellia have any documented side effects to watch for?
Trials generally report Boswellia as well-tolerated, with mild gastrointestinal upset the most commonly noted side effect; as with any supplement, checking in with a doctor is reasonable if you're on other regular medications or have a chronic condition.
Is Boswellia serrata the only species of Boswellia studied for joints?
Most of the clinical trial evidence specifically uses Boswellia serrata extracts, though related species exist in traditional use; when comparing products, it's worth confirming the specific species and standardization match what was actually tested in trials.
Do Boswellia trials typically compare it against NSAIDs directly, or only against placebo?
Most of the strongest trials use placebo comparisons; head-to-head trials against specific NSAIDs are less common for Boswellia than they are for curcumin or the bromelain-containing enzyme combinations discussed elsewhere in this series.
Has Boswellia been studied for joints other than the knee?
The knee osteoarthritis literature is the deepest, though some smaller trials and traditional-use reports discuss Boswellia for other joints and for chronic low back pain, with less consistent trial-level support than the knee-specific data summarized here.
From Nuvirox
Why we formulated Joint+ Restore
We built Joint+ Restore around the categories of joint-support compounds that show up most consistently in the research above — cartilage-matrix building blocks, plant-derived anti-inflammatories, and enzyme cofactors studied for joint comfort. We're not listing exact ingredients or dosages here because the formula is currently being updated; full label specifics will be posted on the product page once the update is finalized. Every bottle comes with a 60-day money-back guarantee — long enough to actually evaluate it the way the research says you should.
Learn more about Joint+ Restore →The bottom line
Short answer: yes, Boswellia serrata has some of the stronger trial support among plant-derived joint supplements, though results vary by extract. That said, treat this as one input among several when deciding how to approach your own joints, not a substitute for a medical evaluation when something feels genuinely wrong.
References
- Majeed M, Majeed S, Narayanan NK, Nagabhushanam K. A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee. Phytother Res. 2019;33(5):1457-1468. DOI: 10.1002/ptr.6338.
- Zhang Y, Gui Y, Adams R, et al. Systematic review and network meta-analysis of Boswellia for knee osteoarthritis. Nutrients. 2025;17(15):2547. DOI: 10.3390/nu17152547. PMID: 40806131.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This article is for informational purposes only and is not a substitute for professional medical advice.